HomeCompareHYFXF vs MRK

HYFXF vs MRK: Dividend Comparison 2026

HYFXF yields 2000000.00% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 HYFXF wins by $6.398209661505228e+29M in total portfolio value
10 years
HYFXF
HYFXF
● Live price
2000000.00%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
-33.9%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$6.398209661505228e+29M
Annual income
$635,892,914,658,037,600,000,000,000,000,000,000.00
Full HYFXF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — HYFXF vs MRK

📍 HYFXF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodHYFXFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, HYFXF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
HYFXF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

HYFXF
Annual income on $10K today (after 15% tax)
$170,000,000.00/yr
After 10yr DRIP, annual income (after tax)
$540,508,977,459,331,940,000,000,000,000,000,000.00/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, HYFXF beats the other by $540,508,977,459,331,940,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of HYFXF + MRK for your $10,000?

HYFXF: 50%MRK: 50%
100% MRK50/50100% HYFXF
Portfolio after 10yr
$3.199104830752614e+29M
Annual income
$317,946,457,329,018,800,000,000,000,000,000,000.00/yr
Blended yield
99.39%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

HYFXF
No analyst data
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

HYFXF buys
0
MRK buys
0
No recent congressional trades found for HYFXF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricHYFXFMRK
Forward yield2000000.00%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-33.9%32.7%
Portfolio after 10y$6.398209661505228e+29M$56.8K
Annual income after 10y$635,892,914,658,037,600,000,000,000,000,000,000.00$9,798.13
Total dividends collected$6.395630758231934e+29M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: HYFXF vs MRK ($10,000, DRIP)

YearHYFXF PortfolioHYFXF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$132,210,700$132,200,000.00$11,206$366.19+$132.20MHYFXF
2$1,079,872,890,770$1,079,731,425,321.50$12,650$502.35+$1079872.88MHYFXF
3$5,449,185,051,324,941$5,448,029,587,331,816.00$14,407$694.19+$5449185051.31MHYFXF
4$16,988,895,053,397,053,000$16,983,064,425,392,136,000.00$16,585$967.82+$16988895053397.04MHYFXF
5$32,727,181,816,053,218,000,000$32,709,003,698,346,087,000,000.00$19,342$1,363.89+$32727181816053216.00MHYFXF
6$38,960,004,830,086,980,000,000,000$38,924,986,745,543,804,000,000,000.00$22,913$1,947.19+$38960004830086979584.00MHYFXF
7$28,667,415,711,339,584,000,000,000,000$28,625,728,506,171,396,000,000,000,000.00$27,662$2,823.89+$2.8667415711339583e+22MHYFXF
8$13,042,665,667,800,610,000,000,000,000,000$13,011,991,532,989,477,000,000,000,000,000.00$34,159$4,173.35+$1.304266566780061e+25MHYFXF
9$3,671,076,161,201,069,000,000,000,000,000,000$3,657,120,508,936,522,400,000,000,000,000,000.00$43,337$6,308.80+$3.671076161201069e+27MHYFXF
10$639,820,966,150,522,700,000,000,000,000,000,000$635,892,914,658,037,600,000,000,000,000,000,000.00$56,776$9,798.13+$6.398209661505228e+29MHYFXF

HYFXF vs MRK: Complete Analysis 2026

HYFXFStock

Hyflux Ltd provides various solutions in water and energy areas worldwide. The company operates through two segments, Municipal and Industrial. The Municipal segment supplies a range of infrastructure solutions, including water, power, and waste-to-energy to municipalities and governments. The Industrial segment supplies infrastructure solutions for water to industrial customers. The company provides seawater desalination, raw water purification, wastewater cleaning, water recycling, water reclamation, and pure water production services to municipal and industrial clients, as well as to home consumers; and filtration and purification products. It also designs, constructs, owns, operates, and sells water treatment, seawater desalination, wastewater treatment, and water recycling plants under service concession arrangements; and sells oxygen-rich water and related products and services. In addition, the company designs, constructs, owns, operates, and sells power plants and waste-to-energy plants; trades in the electricity markets; and sells retail electricity contracts. Hyflux Ltd was founded in 1989 and is headquartered in Singapore.

Full HYFXF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this HYFXF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

HYFXF vs SCHDHYFXF vs JEPIHYFXF vs OHYFXF vs KOHYFXF vs MAINHYFXF vs JNJHYFXF vs ABBVHYFXF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.